Not applicableStudy completedNCT06955910
What this trial is testing
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Who this might be right for
Prostate CancerBladder CancerKidney Cancer
Istituto Oncologico Veneto IRCCS 120